APO Research
Talk to an analyst

APO RESEARCH · REPORT

Transdermal Patch

Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.

Selected research

Market Analysis & Forecast

Global Transdermal Patch Market Analysis and Forecast 2026-2032

21 December 2025200 pages

Choose your research edition.

Industry ResearchTransdermal Patch Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Transdermal Patch Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Transdermal Patch Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transdermal Patch Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Transdermal Patch Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.

Transdermal Patches are mainly classified into the following types: Methyl Salicylate-based Patches, Rivastigmine Patches, Fentanyl Patches, Lidocaine Patches, Diclofenac Patches, Nicotine Patches and others. Methyl Salicylate-based segment accounted for the larger part of the revenue market, with 18%, followed by Lidocaine Patches, with 15%.

Transdermal Patches can delivery drugs through Rx Channel or OTC Channel. The former took a larger market share, with its sales volume accounting for about 76% of the total.

Read the full market overview

Hisamitsu Pharmaceutical, Johnson & Johnson, Nitto Denko and Mylan are the Top 4 players of the global Transdermal Patch market. They took up about 42% of the global market in 2019.

This report presents an overview of global market for Transdermal Patch, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Transdermal Patch, also provides the sales of main regions and countries. Of the upcoming market potential for Transdermal Patch, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Transdermal Patch sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Transdermal Patch market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Transdermal Patch sales, projected growth trends, production technology, application and end-user industry.

Transdermal Patch Segment by Company

Hisamitsu Pharmaceutical

Johnson & Johnson

Novartis

UCB Pharma

Mylan

Teva Pharmaceutical

Nitto Denko

Grünenthal

IBSA Group

GSK

Luye Pharma Group

Pfizer

Chattem

Dr Reddy’s Laboratories

Bayer

Mundipharma

Endo International

Beijing Tide Pharmaceutical

Transdermal Patch Segment by Type

Methyl Salicylate-based Patch

Rivastigmine Transdermal Patch

Fentanyl Transdermal Patch

Lidocaine Patch

Diclofenac Patch

Nicotine Transdermal Patch

Others

Transdermal Patch Segment by Application

Rx Channel

OTC Channel

Transdermal Patch Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transdermal Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Patch.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Transdermal Patch in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Transdermal Patch manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Transdermal Patch sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Transdermal Patch Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Methyl Salicylate-based Patch Major Manufacturers Table 3. Rivastigmine Transdermal Patch Major Manufacturers Table 4. Fentanyl Transdermal Patch Major Manufacturers Table 5. Lidocaine Patch Major Manufacturers Table 6. Diclofenac Patch Major Manufacturers Table 7. Nicotine Transdermal Patch Major Manufacturers Table 8. Others Major Manufacturers Table 9. Global Transdermal Patch Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 10. Rx Channel Major Manufacturers Table 11. OTC Channel Major Manufacturers Table 12. Transdermal Patch Industry Trends Table 13. Transdermal Patch Industry Drivers Table 14. Transdermal Patch Industry Opportunities and Challenges Table 15. Transdermal Patch Industry Restraints Table 16. Global Transdermal Patch Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Transdermal Patch Revenue by Region (2021-2026) & (US$ Million) Table 18. Global Transdermal Patch Revenue by Region (2027-2032) & (US$ Million) Table 19. Global Transdermal Patch Revenue Market Share by Region (2021-2026) Table 20. Global Transdermal Patch Revenue Market Share by Region (2027-2032) Table 21. Global Transdermal Patch Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M Pcs) Table 22. Global Transdermal Patch Sales by Region (2021-2026) & (M Pcs) Table 23. Global Transdermal Patch Sales by Region (2027-2032) & (M Pcs) Table 24. Global Transdermal Patch Sales Market Share by Region (2021-2026) Table 25. Global Transdermal Patch Sales Market Share by Region (2027-2032) Table 26. Global Transdermal Patch Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Transdermal Patch Revenue Market Share by Manufacturers (2021-2026) Table 28. Global Transdermal Patch Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Transdermal Patch Sales Market Share by Manufacturers (2021-2026) Table 30. Global Transdermal Patch Sales Price (USD/Pc) of Manufacturers (2021-2026) Table 31. Global Transdermal Patch Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global Transdermal Patch Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global Transdermal Patch Manufacturers, Product Type & Application Table 34. Global Transdermal Patch Manufacturers' Establishment Date Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global Transdermal Patch by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 37. Global Transdermal Patch Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Transdermal Patch Revenue by Type (2021-2026) & (US$ Million) Table 39. Global Transdermal Patch Revenue by Type (2027-2032) & (US$ Million) Table 40. Global Transdermal Patch Revenue Market Share by Type (2021-2026) Table 41. Global Transdermal Patch Revenue Market Share by Type (2027-2032) Table 42. Global Transdermal Patch Sales by Type 2021 VS 2025 VS 2032 (M Pcs) Table 43. Global Transdermal Patch Sales by Type (2021-2026) & (M Pcs) Table 44. Global Transdermal Patch Sales by Type (2027-2032) & (M Pcs) Table 45. Global Transdermal Patch Sales Market Share by Type (2021-2026) Table 46. Global Transdermal Patch Sales Market Share by Type (2027-2032) Table 47. Global Transdermal Patch Price by Type (2021-2026) & (USD/Pc) Table 48. Global Transdermal Patch Price by Type (2027-2032) & (USD/Pc) Table 49. Global Transdermal Patch Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Transdermal Patch Revenue by Application (2021-2026) & (US$ Million) Table 51. Global Transdermal Patch Revenue by Application (2027-2032) & (US$ Million) Table 52. Global Transdermal Patch Revenue Market Share by Application (2021-2026) Table 53. Global Transdermal Patch Revenue Market Share by Application (2027-2032) Table 54. Global Transdermal Patch Sales by Application 2021 VS 2025 VS 2032 (M Pcs) Table 55. Global Transdermal Patch Sales by Application (2021-2026) & (M Pcs) Table 56. Global Transdermal Patch Sales by Application (2027-2032) & (M Pcs) Table 57. Global Transdermal Patch Sales Market Share by Application (2021-2026) Table 58. Global Transdermal Patch Sales Market Share by Application (2027-2032) Table 59. Global Transdermal Patch Price by Application (2021-2026) & (USD/Pc) Table 60. Global Transdermal Patch Price by Application (2027-2032) & (USD/Pc) Table 61. Hisamitsu Pharmaceutical Company Information Table 62. Hisamitsu Pharmaceutical Business Overview Table 63. Hisamitsu Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2021-2026) Table 64. Hisamitsu Pharmaceutical Transdermal Patch Product Portfolio Table 65. Hisamitsu Pharmaceutical Recent Development Table 66. Johnson & Johnson Company Information Table 67. Johnson & Johnson Business Overview Table 68. Johnson & Johnson Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2021-2026) Table 69. Johnson & Johnson Transdermal Patch Product Portfolio Table 70. Johnson & Johnson Recent Development Table 71. Novartis Company Information Table 72. Novartis Business Overview Table 73. Novartis Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2021-2026) Table 74. Novartis Transdermal Patch Product Portfolio Table 75. Novartis Recent Development Table 76. UCB Pharma Company Information Table 77. UCB Pharma Business Overview Table 78. UCB Pharma Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2021-2026) Table 79. UCB Pharma Transdermal Patch Product Portfolio Table 80. UCB Pharma Recent Development Table 81. Mylan Company Information Table 82. Mylan Business Overview Table 83. Mylan Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2021-2026) Table 84. Mylan Transdermal Patch Product Portfolio Table 85. Mylan Recent Development Table 86. Teva Pharmaceutical Company Information Table 87. Teva Pharmaceutical Business Overview Table 88. Teva Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2021-2026) Table 89. Teva Pharmaceutical Transdermal Patch Product Portfolio Table 90. Teva Pharmaceutical Recent Development Table 91. Nitto Denko Company Information Table 92. Nitto Denko Business Overview Table 93. Nitto Denko Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2021-2026) Table 94. Nitto Denko Transdermal Patch Product Portfolio Table 95. Nitto Denko Recent Development Table 96. Grünenthal Company Information Table 97. Grünenthal Business Overview Table 98. Grünenthal Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2021-2026) Table 99. Grünenthal Transdermal Patch Product Portfolio Table 100. Grünenthal Recent Development Table 101. IBSA Group Company Information Table 102. IBSA Group Business Overview Table 103. IBSA Group Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2021-2026) Table 104. IBSA Group Transdermal Patch Product Portfolio Table 105. IBSA Group Recent Development Table 106. GSK Company Information Table 107. GSK Business Overview Table 108. GSK Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2021-2026) Table 109. GSK Transdermal Patch Product Portfolio Table 110. GSK Recent Development Table 111. Luye Pharma Group Company Information Table 112. Luye Pharma Group Business Overview Table 113. Luye Pharma Group Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2021-2026) Table 114. Luye Pharma Group Transdermal Patch Product Portfolio Table 115. Luye Pharma Group Recent Development Table 116. Pfizer Company Information Table 117. Pfizer Business Overview Table 118. Pfizer Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2021-2026) Table 119. Pfizer Transdermal Patch Product Portfolio Table 120. Pfizer Recent Development Table 121. Chattem Company Information Table 122. Chattem Business Overview Table 123. Chattem Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2021-2026) Table 124. Chattem Transdermal Patch Product Portfolio Table 125. Chattem Recent Development Table 126. Dr Reddy’s Laboratories Company Information Table 127. Dr Reddy’s Laboratories Business Overview Table 128. Dr Reddy’s Laboratories Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2021-2026) Table 129. Dr Reddy’s Laboratories Transdermal Patch Product Portfolio Table 130. Dr Reddy’s Laboratories Recent Development Table 131. Bayer Company Information Table 132. Bayer Business Overview Table 133. Bayer Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2021-2026) Table 134. Bayer Transdermal Patch Product Portfolio Table 135. Bayer Recent Development Table 136. Mundipharma Company Information Table 137. Mundipharma Business Overview Table 138. Mundipharma Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2021-2026) Table 139. Mundipharma Transdermal Patch Product Portfolio Table 140. Mundipharma Recent Development Table 141. Endo International Company Information Table 142. Endo International Business Overview Table 143. Endo International Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2021-2026) Table 144. Endo International Transdermal Patch Product Portfolio Table 145. Endo International Recent Development Table 146. Beijing Tide Pharmaceutical Company Information Table 147. Beijing Tide Pharmaceutical Business Overview Table 148. Beijing Tide Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2021-2026) Table 149. Beijing Tide Pharmaceutical Transdermal Patch Product Portfolio Table 150. Beijing Tide Pharmaceutical Recent Development Table 151. North America Transdermal Patch Revenue by Type (2021-2026) & (US$ Million) Table 152. North America Transdermal Patch Revenue by Type (2027-2032) & (US$ Million) Table 153. North America Transdermal Patch Sales by Type (2021-2026) & (M Pcs) Table 154. North America Transdermal Patch Sales by Type (2027-2032) & (M Pcs) Table 155. North America Transdermal Patch Sales Price by Type (2021-2026) & (USD/Pc) Table 156. North America Transdermal Patch Sales Price by Type (2027-2032) & (USD/Pc) Table 157. North America Transdermal Patch Revenue by Application (2021-2026) & (US$ Million) Table 158. North America Transdermal Patch Revenue by Application (2027-2032) & (US$ Million) Table 159. North America Transdermal Patch Sales by Application (2021-2026) & (M Pcs) Table 160. North America Transdermal Patch Sales by Application (2027-2032) & (M Pcs) Table 161. North America Transdermal Patch Sales Price by Application (2021-2026) & (USD/Pc) Table 162. North America Transdermal Patch Sales Price by Application (2027-2032) & (USD/Pc) Table 163. North America Transdermal Patch Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 164. North America Transdermal Patch Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 165. North America Transdermal Patch Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 166. North America Transdermal Patch Sales by Country (2021 VS 2025 VS 2032) & (M Pcs) Table 167. North America Transdermal Patch Sales by Country (2021-2026) & (M Pcs) Table 168. North America Transdermal Patch Sales by Country (2027-2032) & (M Pcs) Table 169. North America Transdermal Patch Sales Price by Country (2021-2026) & (USD/Pc) Table 170. North America Transdermal Patch Sales Price by Country (2027-2032) & (USD/Pc) Table 171. United States Transdermal Patch Revenue (2021-2032) & (US$ Million) Table 172. Canada Transdermal Patch Revenue (2021-2032) & (US$ Million) Table 173. Mexico Transdermal Patch Revenue (2021-2032) & (US$ Million) Table 174. Europe Transdermal Patch Revenue by Type (2021-2026) & (US$ Million) Table 175. Europe Transdermal Patch Revenue by Type (2027-2032) & (US$ Million) Table 176. Europe Transdermal Patch Sales by Type (2021-2026) & (M Pcs) Table 177. Europe Transdermal Patch Sales by Type (2027-2032) & (M Pcs) Table 178. Europe Transdermal Patch Sales Price by Type (2021-2026) & (USD/Pc) Table 179. Europe Transdermal Patch Sales Price by Type (2027-2032) & (USD/Pc) Table 180. Europe Transdermal Patch Revenue by Application (2021-2026) & (US$ Million) Table 181. Europe Transdermal Patch Revenue by Application (2027-2032) & (US$ Million) Table 182. Europe Transdermal Patch Sales by Application (2021-2026) & (M Pcs) Table 183. Europe Transdermal Patch Sales by Application (2027-2032) & (M Pcs) Table 184. Europe Transdermal Patch Sales Price by Application (2021-2026) & (USD/Pc) Table 185. Europe Transdermal Patch Sales Price by Application (2027-2032) & (USD/Pc) Table 186. Europe Transdermal Patch Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 187. Europe Transdermal Patch Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 188. Europe Transdermal Patch Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 189. Europe Transdermal Patch Sales by Country (2021 VS 2025 VS 2032) & (M Pcs) Table 190. Europe Transdermal Patch Sales by Country (2021-2026) & (M Pcs) Table 191. Europe Transdermal Patch Sales by Country (2027-2032) & (M Pcs) Table 192. Europe Transdermal Patch Sales Price by Country (2021-2026) & (USD/Pc) Table 193. Europe Transdermal Patch Sales Price by Country (2027-2032) & (USD/Pc) Table 194. Germany Transdermal Patch Revenue (2021-2032) & (US$ Million) Table 195. France Transdermal Patch Revenue (2021-2032) & (US$ Million) Table 196. U.K. Transdermal Patch Revenue (2021-2032) & (US$ Million) Table 197. Italy Transdermal Patch Revenue (2021-2032) & (US$ Million) Table 198. Russia Transdermal Patch Revenue (2021-2032) & (US$ Million) Table 199. Spain Transdermal Patch Revenue (2021-2032) & (US$ Million) Table 200. Netherlands Transdermal Patch Revenue (2021-2032) & (US$ Million) Table 201. Switzerland Transdermal Patch Revenue (2021-2032) & (US$ Million) Table 202. Sweden Transdermal Patch Revenue (2021-2032) & (US$ Million) Table 203. Poland Transdermal Patch Revenue (2021-2032) & (US$ Million) Table 204. China Transdermal Patch Revenue by Type (2021-2026) & (US$ Million) Table 205. China Transdermal Patch Revenue by Type (2027-2032) & (US$ Million) Table 206. China Transdermal Patch Sales by Type (2021-2026) & (M Pcs) Table 207. China Transdermal Patch Sales by Type (2027-2032) & (M Pcs) Table 208. China Transdermal Patch Sales Price by Type (2021-2026) & (USD/Pc) Table 209. China Transdermal Patch Sales Price by Type (2027-2032) & (USD/Pc) Table 210. China Transdermal Patch Revenue by Application (2021-2026) & (US$ Million) Table 211. China Transdermal Patch Revenue by Application (2027-2032) & (US$ Million) Table 212. China Transdermal Patch Sales by Application (2021-2026) & (M Pcs) Table 213. China Transdermal Patch Sales by Application (2027-2032) & (M Pcs) Table 214. China Transdermal Patch Sales Price by Application (2021-2026) & (USD/Pc) Table 215. China Transdermal Patch Sales Price by Application (2027-2032) & (USD/Pc) Table 216. Asia Transdermal Patch Revenue by Type (2021-2026) & (US$ Million) Table 217. Asia Transdermal Patch Revenue by Type (2027-2032) & (US$ Million) Table 218. Asia Transdermal Patch Sales by Type (2021-2026) & (M Pcs) Table 219. Asia Transdermal Patch Sales by Type (2027-2032) & (M Pcs) Table 220. Asia Transdermal Patch Sales Price by Type (2021-2026) & (USD/Pc) Table 221. Asia Transdermal Patch Sales Price by Type (2027-2032) & (USD/Pc) Table 222. Asia Transdermal Patch Revenue by Application (2021-2026) & (US$ Million) Table 223. Asia Transdermal Patch Revenue by Application (2027-2032) & (US$ Million) Table 224. Asia Transdermal Patch Sales by Application (2021-2026) & (M Pcs) Table 225. Asia Transdermal Patch Sales by Application (2027-2032) & (M Pcs) Table 226. Asia Transdermal Patch Sales Price by Application (2021-2026) & (USD/Pc) Table 227. Asia Transdermal Patch Sales Price by Application (2027-2032) & (USD/Pc) Table 228. Asia Transdermal Patch Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 229. Asia Transdermal Patch Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 230. Asia Transdermal Patch Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 231. Asia Transdermal Patch Sales by Country (2021 VS 2025 VS 2032) & (M Pcs) Table 232. Asia Transdermal Patch Sales by Country (2021-2026) & (M Pcs) Table 233. Asia Transdermal Patch Sales by Country (2027-2032) & (M Pcs) Table 234. Asia Transdermal Patch Sales Price by Country (2021-2026) & (USD/Pc) Table 235. Asia Transdermal Patch Sales Price by Country (2027-2032) & (USD/Pc) Table 236. Japan Transdermal Patch Revenue (2021-2032) & (US$ Million) Table 237. South Korea Transdermal Patch Revenue (2021-2032) & (US$ Million) Table 238. India Transdermal Patch Revenue (2021-2032) & (US$ Million) Table 239. Australia Transdermal Patch Revenue (2021-2032) & (US$ Million) Table 240. Taiwan Transdermal Patch Revenue (2021-2032) & (US$ Million) Table 241. Southeast Asia Transdermal Patch Revenue (2021-2032) & (US$ Million) Table 242. SAMEA Transdermal Patch Revenue by Type (2021-2026) & (US$ Million) Table 243. SAMEA Transdermal Patch Revenue by Type (2027-2032) & (US$ Million) Table 244. SAMEA Transdermal Patch Sales by Type (2021-2026) & (M Pcs) Table 245. SAMEA Transdermal Patch Sales by Type (2027-2032) & (M Pcs) Table 246. SAMEA Transdermal Patch Sales Price by Type (2021-2026) & (USD/Pc) Table 247. SAMEA Transdermal Patch Sales Price by Type (2027-2032) & (USD/Pc) Table 248. SAMEA Transdermal Patch Revenue by Application (2021-2026) & (US$ Million) Table 249. SAMEA Transdermal Patch Revenue by Application (2027-2032) & (US$ Million) Table 250. SAMEA Transdermal Patch Sales by Application (2021-2026) & (M Pcs) Table 251. SAMEA Transdermal Patch Sales by Application (2027-2032) & (M Pcs) Table 252. SAMEA Transdermal Patch Sales Price by Application (2021-2026) & (USD/Pc) Table 253. SAMEA Transdermal Patch Sales Price by Application (2027-2032) & (USD/Pc) Table 254. SAMEA Transdermal Patch Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 255. SAMEA Transdermal Patch Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 256. SAMEA Transdermal Patch Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 257. SAMEA Transdermal Patch Sales by Country (2021 VS 2025 VS 2032) & (M Pcs) Table 258. SAMEA Transdermal Patch Sales by Country (2021-2026) & (M Pcs) Table 259. SAMEA Transdermal Patch Sales by Country (2027-2032) & (M Pcs) Table 260. SAMEA Transdermal Patch Sales Price by Country (2021-2026) & (USD/Pc) Table 261. SAMEA Transdermal Patch Sales Price by Country (2027-2032) & (USD/Pc) Table 262. Brazil Transdermal Patch Revenue (2021-2032) & (US$ Million) Table 263. Argentina Transdermal Patch Revenue (2021-2032) & (US$ Million) Table 264. Chile Transdermal Patch Revenue (2021-2032) & (US$ Million) Table 265. Colombia Transdermal Patch Revenue (2021-2032) & (US$ Million) Table 266. Peru Transdermal Patch Revenue (2021-2032) & (US$ Million) Table 267. Saudi Arabia Transdermal Patch Revenue (2021-2032) & (US$ Million) Table 268. Israel Transdermal Patch Revenue (2021-2032) & (US$ Million) Table 269. UAE Transdermal Patch Revenue (2021-2032) & (US$ Million) Table 270. Turkey Transdermal Patch Revenue (2021-2032) & (US$ Million) Table 271. Iran Transdermal Patch Revenue (2021-2032) & (US$ Million) Table 272. Egypt Transdermal Patch Revenue (2021-2032) & (US$ Million) Table 273. Key Raw Materials Table 274. Raw Materials Key Suppliers Table 275. Transdermal Patch Distributors List Table 276. Transdermal Patch Customers List Table 277. Research Programs/Design for This Report Table 278. Authors List of This Report Table 279. Secondary Sources Table 280. Primary Sources List of Figures Figure 1. Transdermal Patch Image Figure 2. Global Transdermal Patch Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Transdermal Patch Market Size Share 2021 VS 2025 VS 2032 Figure 4. Methyl Salicylate-based Patch Image Figure 5. Rivastigmine Transdermal Patch Image Figure 6. Fentanyl Transdermal Patch Image Figure 7. Lidocaine Patch Image Figure 8. Diclofenac Patch Image Figure 9. Nicotine Transdermal Patch Image Figure 10. Others Image Figure 11. Global Transdermal Patch Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Transdermal Patch Market Size Share 2021 VS 2025 VS 2032 Figure 13. Rx Channel Image Figure 14. OTC Channel Image Figure 15. Global Transdermal Patch Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Transdermal Patch Revenue (2021-2032) & (US$ Million) Figure 17. Global Transdermal Patch Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Transdermal Patch Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global Transdermal Patch Revenue Market Share by Region (2021-2032) Figure 20. Global Transdermal Patch Sales (2021-2032) & (M Pcs) Figure 21. Global Transdermal Patch Sales by Region: 2021 VS 2025 VS 2032 (M Pcs) Figure 22. Global Transdermal Patch Sales Market Share by Region (2021-2032) Figure 23. US & Canada & Mexico Transdermal Patch Sales YoY (2021-2032) & (M Pcs) Figure 24. Europe Transdermal Patch Sales YoY (2021-2032) & (M Pcs) Figure 25. China Transdermal Patch Sales YoY (2021-2032) & (M Pcs) Figure 26. Asia (Excluding China) Transdermal Patch Sales YoY (2021-2032) & (M Pcs) Figure 27. South America, Middle East and Africa Transdermal Patch Sales YoY (2021-2032) & (M Pcs) Figure 28. Global Transdermal Patch Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global Transdermal Patch Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global Transdermal Patch Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 32. Global Transdermal Patch Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Transdermal Patch Revenue Market Share by Type (2021-2032) Figure 34. Global Transdermal Patch Sales by Type (2021 VS 2025 VS 2032) & (M Pcs) Figure 35. Global Transdermal Patch Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Transdermal Patch Sales Market Share by Type (2021-2032) Figure 37. Global Transdermal Patch Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 38. Global Transdermal Patch Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Transdermal Patch Revenue Market Share by Application (2021-2032) Figure 40. Global Transdermal Patch Sales by Application (2021 VS 2025 VS 2032) & (M Pcs) Figure 41. Global Transdermal Patch Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Transdermal Patch Sales Market Share by Application (2021-2032) Figure 43. North America Transdermal Patch Revenue Share by Type (2021-2032) Figure 44. North America Transdermal Patch Sales Share by Type (2021-2032) Figure 45. North America Transdermal Patch Revenue Share by Application (2021-2032) Figure 46. North America Transdermal Patch Sales Share by Application (2021-2032) Figure 47. North America Transdermal Patch Revenue Share by Country (2021-2032) Figure 48. North America Transdermal Patch Sales Share by Country (2021-2032) Figure 49. Europe Transdermal Patch Revenue Share by Type (2021-2032) Figure 50. Europe Transdermal Patch Sales Share by Type (2021-2032) Figure 51. Europe Transdermal Patch Revenue Share by Application (2021-2032) Figure 52. Europe Transdermal Patch Sales Share by Application (2021-2032) Figure 53. Europe Transdermal Patch Revenue Share by Country (2021-2032) Figure 54. Europe Transdermal Patch Sales Share by Country (2021-2032) Figure 55. China Transdermal Patch Revenue Share by Type (2021-2032) Figure 56. China Transdermal Patch Sales Share by Type (2021-2032) Figure 57. China Transdermal Patch Revenue Share by Application (2021-2032) Figure 58. China Transdermal Patch Sales Share by Application (2021-2032) Figure 59. Asia Transdermal Patch Revenue Share by Type (2021-2032) Figure 60. Asia Transdermal Patch Sales Share by Type (2021-2032) Figure 61. Asia Transdermal Patch Revenue Share by Application (2021-2032) Figure 62. Asia Transdermal Patch Sales Share by Application (2021-2032) Figure 63. Asia Transdermal Patch Revenue Share by Country (2021-2032) Figure 64. Asia Transdermal Patch Sales Share by Country (2021-2032) Figure 65. SAMEA Transdermal Patch Revenue Share by Type (2021-2032) Figure 66. SAMEA Transdermal Patch Sales Share by Type (2021-2032) Figure 67. SAMEA Transdermal Patch Revenue Share by Application (2021-2032) Figure 68. SAMEA Transdermal Patch Sales Share by Application (2021-2032) Figure 69. SAMEA Transdermal Patch Revenue Share by Country (2021-2032) Figure 70. SAMEA Transdermal Patch Sales Share by Country (2021-2032) Figure 71. Transdermal Patch Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Transdermal Patch Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Methyl Salicylate-based Patch
  • Rivastigmine Transdermal Patch
  • Fentanyl Transdermal Patch
  • Lidocaine Patch
  • Diclofenac Patch
  • Nicotine Transdermal Patch
  • Others
Applications
  • Rx Channel
  • OTC Channel
Companies covered
  • Hisamitsu Pharmaceutical
  • Johnson & Johnson
  • Novartis
  • UCB Pharma
  • Mylan
  • Teva Pharmaceutical
  • Nitto Denko
  • Grünenthal
  • IBSA Group
  • GSK
  • Luye Pharma Group
  • Pfizer
  • Chattem
  • Dr Reddy’s Laboratories
  • Bayer
  • Mundipharma
  • Endo International
  • Beijing Tide Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Transdermal Patch Market by Type
  3. 1.2.1 Global Transdermal Patch Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Methyl Salicylate-based Patch
  5. 1.2.3 Rivastigmine Transdermal Patch
  6. 1.2.4 Fentanyl Transdermal Patch
  7. 1.2.5 Lidocaine Patch
  8. 1.2.6 Diclofenac Patch
  9. 1.2.7 Nicotine Transdermal Patch
  10. 1.2.8 Others
  11. 1.3 Transdermal Patch Market by Application
  12. 1.3.1 Global Transdermal Patch Market Size by Application, 2021 VS 2025 VS 2032
  13. 1.3.2 Rx Channel
  14. 1.3.3 OTC Channel
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Transdermal Patch Market Dynamics
  1. 2.1 Transdermal Patch Industry Trends
  2. 2.2 Transdermal Patch Industry Drivers
  3. 2.3 Transdermal Patch Industry Opportunities and Challenges
  4. 2.4 Transdermal Patch Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Transdermal Patch Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Transdermal Patch Revenue by Region
  3. 3.2.1 Global Transdermal Patch Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Transdermal Patch Revenue by Region (2021-2026)
  5. 3.2.3 Global Transdermal Patch Revenue by Region (2027-2032)
  6. 3.2.4 Global Transdermal Patch Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Transdermal Patch Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Transdermal Patch Sales by Region
  9. 3.4.1 Global Transdermal Patch Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Transdermal Patch Sales by Region (2021-2026)
  11. 3.4.3 Global Transdermal Patch Sales by Region (2027-2032)
  12. 3.4.4 Global Transdermal Patch Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Transdermal Patch Revenue by Manufacturers
  2. 4.1.1 Global Transdermal Patch Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Transdermal Patch Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Transdermal Patch Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Transdermal Patch Sales by Manufacturers
  6. 4.2.1 Global Transdermal Patch Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Transdermal Patch Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Transdermal Patch Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Transdermal Patch Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Transdermal Patch Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Transdermal Patch Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Transdermal Patch Manufacturers, Product Type & Application
  13. 4.7 Global Transdermal Patch Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Transdermal Patch Market CR5 and HHI
  16. 4.8.2 2025 Transdermal Patch Tier 1, Tier 2, and Tier 3
5 Transdermal Patch Market by Type
  1. 5.1 Global Transdermal Patch Revenue by Type
  2. 5.1.1 Global Transdermal Patch Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Transdermal Patch Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Transdermal Patch Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Transdermal Patch Sales by Type
  6. 5.2.1 Global Transdermal Patch Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Transdermal Patch Sales by Type (2021-2032) & (M Pcs)
  8. 5.2.3 Global Transdermal Patch Sales Market Share by Type (2021-2032)
  9. 5.3 Global Transdermal Patch Price by Type
6 Transdermal Patch Market by Application
  1. 6.1 Global Transdermal Patch Revenue by Application
  2. 6.1.1 Global Transdermal Patch Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Transdermal Patch Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Transdermal Patch Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Transdermal Patch Sales by Application
  6. 6.2.1 Global Transdermal Patch Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Transdermal Patch Sales by Application (2021-2032) & (M Pcs)
  8. 6.2.3 Global Transdermal Patch Sales Market Share by Application (2021-2032)
  9. 6.3 Global Transdermal Patch Price by Application
7 Company Profiles
  1. 7.1 Hisamitsu Pharmaceutical
  2. 7.1.1 Hisamitsu Pharmaceutical Company Information
  3. 7.1.2 Hisamitsu Pharmaceutical Business Overview
  4. 7.1.3 Hisamitsu Pharmaceutical Transdermal Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Hisamitsu Pharmaceutical Transdermal Patch Product Portfolio
  6. 7.1.5 Hisamitsu Pharmaceutical Recent Developments
  7. 7.2 Johnson & Johnson
  8. 7.2.1 Johnson & Johnson Company Information
  9. 7.2.2 Johnson & Johnson Business Overview
  10. 7.2.3 Johnson & Johnson Transdermal Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Johnson & Johnson Transdermal Patch Product Portfolio
  12. 7.2.5 Johnson & Johnson Recent Developments
  13. 7.3 Novartis
  14. 7.3.1 Novartis Company Information
  15. 7.3.2 Novartis Business Overview
  16. 7.3.3 Novartis Transdermal Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Novartis Transdermal Patch Product Portfolio
  18. 7.3.5 Novartis Recent Developments
  19. 7.4 UCB Pharma
  20. 7.4.1 UCB Pharma Company Information
  21. 7.4.2 UCB Pharma Business Overview
  22. 7.4.3 UCB Pharma Transdermal Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 UCB Pharma Transdermal Patch Product Portfolio
  24. 7.4.5 UCB Pharma Recent Developments
  25. 7.5 Mylan
  26. 7.5.1 Mylan Company Information
  27. 7.5.2 Mylan Business Overview
  28. 7.5.3 Mylan Transdermal Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Mylan Transdermal Patch Product Portfolio
  30. 7.5.5 Mylan Recent Developments
  31. 7.6 Teva Pharmaceutical
  32. 7.6.1 Teva Pharmaceutical Company Information
  33. 7.6.2 Teva Pharmaceutical Business Overview
  34. 7.6.3 Teva Pharmaceutical Transdermal Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Teva Pharmaceutical Transdermal Patch Product Portfolio
  36. 7.6.5 Teva Pharmaceutical Recent Developments
  37. 7.7 Nitto Denko
  38. 7.7.1 Nitto Denko Company Information
  39. 7.7.2 Nitto Denko Business Overview
  40. 7.7.3 Nitto Denko Transdermal Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Nitto Denko Transdermal Patch Product Portfolio
  42. 7.7.5 Nitto Denko Recent Developments
  43. 7.8 Grünenthal
  44. 7.8.1 Grünenthal Company Information
  45. 7.8.2 Grünenthal Business Overview
  46. 7.8.3 Grünenthal Transdermal Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Grünenthal Transdermal Patch Product Portfolio
  48. 7.8.5 Grünenthal Recent Developments
  49. 7.9 IBSA Group
  50. 7.9.1 IBSA Group Company Information
  51. 7.9.2 IBSA Group Business Overview
  52. 7.9.3 IBSA Group Transdermal Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 IBSA Group Transdermal Patch Product Portfolio
  54. 7.9.5 IBSA Group Recent Developments
  55. 7.10 GSK
  56. 7.10.1 GSK Company Information
  57. 7.10.2 GSK Business Overview
  58. 7.10.3 GSK Transdermal Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 GSK Transdermal Patch Product Portfolio
  60. 7.10.5 GSK Recent Developments
  61. 7.11 Luye Pharma Group
  62. 7.11.1 Luye Pharma Group Company Information
  63. 7.11.2 Luye Pharma Group Business Overview
  64. 7.11.3 Luye Pharma Group Transdermal Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Luye Pharma Group Transdermal Patch Product Portfolio
  66. 7.11.5 Luye Pharma Group Recent Developments
  67. 7.12 Pfizer
  68. 7.12.1 Pfizer Company Information
  69. 7.12.2 Pfizer Business Overview
  70. 7.12.3 Pfizer Transdermal Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Pfizer Transdermal Patch Product Portfolio
  72. 7.12.5 Pfizer Recent Developments
  73. 7.13 Chattem
  74. 7.13.1 Chattem Company Information
  75. 7.13.2 Chattem Business Overview
  76. 7.13.3 Chattem Transdermal Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Chattem Transdermal Patch Product Portfolio
  78. 7.13.5 Chattem Recent Developments
  79. 7.14 Dr Reddy’s Laboratories
  80. 7.14.1 Dr Reddy’s Laboratories Company Information
  81. 7.14.2 Dr Reddy’s Laboratories Business Overview
  82. 7.14.3 Dr Reddy’s Laboratories Transdermal Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Dr Reddy’s Laboratories Transdermal Patch Product Portfolio
  84. 7.14.5 Dr Reddy’s Laboratories Recent Developments
  85. 7.15 Bayer
  86. 7.15.1 Bayer Company Information
  87. 7.15.2 Bayer Business Overview
  88. 7.15.3 Bayer Transdermal Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Bayer Transdermal Patch Product Portfolio
  90. 7.15.5 Bayer Recent Developments
  91. 7.16 Mundipharma
  92. 7.16.1 Mundipharma Company Information
  93. 7.16.2 Mundipharma Business Overview
  94. 7.16.3 Mundipharma Transdermal Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Mundipharma Transdermal Patch Product Portfolio
  96. 7.16.5 Mundipharma Recent Developments
  97. 7.17 Endo International
  98. 7.17.1 Endo International Company Information
  99. 7.17.2 Endo International Business Overview
  100. 7.17.3 Endo International Transdermal Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Endo International Transdermal Patch Product Portfolio
  102. 7.17.5 Endo International Recent Developments
  103. 7.18 Beijing Tide Pharmaceutical
  104. 7.18.1 Beijing Tide Pharmaceutical Company Information
  105. 7.18.2 Beijing Tide Pharmaceutical Business Overview
  106. 7.18.3 Beijing Tide Pharmaceutical Transdermal Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Beijing Tide Pharmaceutical Transdermal Patch Product Portfolio
  108. 7.18.5 Beijing Tide Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Transdermal Patch Market Size by Type
  2. 8.1.1 North America Transdermal Patch Revenue by Type (2021-2032)
  3. 8.1.2 North America Transdermal Patch Sales by Type (2021-2032)
  4. 8.1.3 North America Transdermal Patch Price by Type (2021-2032)
  5. 8.2 North America Transdermal Patch Market Size by Application
  6. 8.2.1 North America Transdermal Patch Revenue by Application (2021-2032)
  7. 8.2.2 North America Transdermal Patch Sales by Application (2021-2032)
  8. 8.2.3 North America Transdermal Patch Price by Application (2021-2032)
  9. 8.3 North America Transdermal Patch Market Size by Country
  10. 8.3.1 North America Transdermal Patch Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Transdermal Patch Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Transdermal Patch Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Transdermal Patch Market Size by Type
  2. 9.1.1 Europe Transdermal Patch Revenue by Type (2021-2032)
  3. 9.1.2 Europe Transdermal Patch Sales by Type (2021-2032)
  4. 9.1.3 Europe Transdermal Patch Price by Type (2021-2032)
  5. 9.2 Europe Transdermal Patch Market Size by Application
  6. 9.2.1 Europe Transdermal Patch Revenue by Application (2021-2032)
  7. 9.2.2 Europe Transdermal Patch Sales by Application (2021-2032)
  8. 9.2.3 Europe Transdermal Patch Price by Application (2021-2032)
  9. 9.3 Europe Transdermal Patch Market Size by Country
  10. 9.3.1 Europe Transdermal Patch Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Transdermal Patch Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Transdermal Patch Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Transdermal Patch Market Size by Type
  2. 10.1.1 China Transdermal Patch Revenue by Type (2021-2032)
  3. 10.1.2 China Transdermal Patch Sales by Type (2021-2032)
  4. 10.1.3 China Transdermal Patch Price by Type (2021-2032)
  5. 10.2 China Transdermal Patch Market Size by Application
  6. 10.2.1 China Transdermal Patch Revenue by Application (2021-2032)
  7. 10.2.2 China Transdermal Patch Sales by Application (2021-2032)
  8. 10.2.3 China Transdermal Patch Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Transdermal Patch Market Size by Type
  2. 11.1.1 Asia Transdermal Patch Revenue by Type (2021-2032)
  3. 11.1.2 Asia Transdermal Patch Sales by Type (2021-2032)
  4. 11.1.3 Asia Transdermal Patch Price by Type (2021-2032)
  5. 11.2 Asia Transdermal Patch Market Size by Application
  6. 11.2.1 Asia Transdermal Patch Revenue by Application (2021-2032)
  7. 11.2.2 Asia Transdermal Patch Sales by Application (2021-2032)
  8. 11.2.3 Asia Transdermal Patch Price by Application (2021-2032)
  9. 11.3 Asia Transdermal Patch Market Size by Country
  10. 11.3.1 Asia Transdermal Patch Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Transdermal Patch Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Transdermal Patch Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Transdermal Patch Market Size by Type
  2. 12.1.1 SAMEA Transdermal Patch Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Transdermal Patch Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Transdermal Patch Price by Type (2021-2032)
  5. 12.2 SAMEA Transdermal Patch Market Size by Application
  6. 12.2.1 SAMEA Transdermal Patch Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Transdermal Patch Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Transdermal Patch Price by Application (2021-2032)
  9. 12.3 SAMEA Transdermal Patch Market Size by Country
  10. 12.3.1 SAMEA Transdermal Patch Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Transdermal Patch Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Transdermal Patch Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Transdermal Patch Value Chain Analysis
  2. 13.1.1 Transdermal Patch Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Transdermal Patch Production Mode & Process
  6. 13.2 Transdermal Patch Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Transdermal Patch Distributors
  9. 13.2.3 Transdermal Patch Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst